The pandemic coronavirus disease 19 (COVID-19), caused by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2), has been spread rapidly worldwide with …

Purpose Given the coronavirus disease 2019 (COVID-19) pandemic, there is a global
urgency to discover an effective treatment for patients withthis disease. This study aimed to …

Background Severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) has changed
our lives. The scientific community has been investigating re-purposed treatments to prevent …

The current management of COVID-19 is mostly limited to general supportive care and
symptomatic treatment. Ivermectin is a broad-spectrum anti-parasitic drug used widely for …

Background Ivermectin was shown to inhibit severe acute respiratory syndrome coronavirus
2 replication in vitro, which has led to off-label use, but clinical efficacy has not been …

Background and objectives: Various existing non-antiviral drugs are being used to treat
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection based mostly on …

Background and objectives An effective treatment option is not yet available for SARS-CoV2,
which causes the COVID-19 pandemic and whose effects are felt more and more every day …

Objectives To assess the efficacy of ivermectin in addition to standard treatment compared to
standard treatment alone in reducing hospitalizations in the COVID-19 patient population …

During the first year of the COVID-19 pandemic, unauthorized drugs were widely used.
Ivermectin and hydroxychloroquine are drugs that inhibit viral replication in vitro and that …

Objective: To evaluate different doses of ivermectin in adult patients with mild COVID-19 and
to evaluate the effect of ivermectin on mortality and clinical consequences. Methods: A …